BioAgilytix provides specialized bioanalytical testing services for the pharmaceutical, biotechnology, and agricultural biotechnology industries. Their services include a variety of assays, such as pharmacokinetics (PK) and pharmacodynamics (PD) assays, which analyze how drugs behave in the body, as well as cell-based assays that test drug effects on living cells and immunogenicity assays that assess immune responses to drugs. With a laboratory in Hamburg, Germany, BioAgilytix operates globally and supports clients in developing and validating new treatments, ensuring the safety and efficacy of agricultural products, and has also contributed to COVID-19 testing efforts. Unlike many competitors, BioAgilytix focuses specifically on large molecule studies, making them a crucial partner for companies in the life sciences sector. Their goal is to facilitate the development and approval of new drugs and therapies through their comprehensive testing services.